Elita platform combines dog stem cells with health data to help predict, prevent, and treat disease before symptoms appear.
Elita has raised $1.4M in total funding. The most recent round was Seed. The last funding was announced in September 2026.
Elita's investors include Boost VC, Startmate, LaunchVic, Archangel Ventures, Gandel Invest.
Elita is headquartered in Melbourne, Australia.
Elita platform combines dog stem cells with health data to help predict, prevent, and treat disease before symptoms appear.
Elita is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Elita — Funding & Investors." VCBacked, September 14, 2026, https://www.vcbacked.co/company/elita. Accessed November 13, 2026.
VCBacked. (2026). Elita — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/elita
{{cite web |title=Elita — Funding & Investors |url=https://www.vcbacked.co/company/elita |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Elita? Request a listing update